ReviewPharmaceuticals (Basel, Switzerland)2021

The Evaluation of Drug Delivery Nanocarrier Development and Pharmacological Briefing for Metabolic-Associated Fatty Liver Disease (MAFLD): An Update.

Reem Abou Assi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.